Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from M3 ( (JP:2413) ) is now available.
M3, Inc. reported its consolidated financial results for the fiscal year ended March 31, 2025, showing a 19.3% increase in revenue to 284,900 million yen. Despite the revenue growth, the company experienced a decline in operating profit by 2.2% and profit attributable to owners of the parent by 10.6%. The financial results indicate challenges in maintaining profit margins despite increased revenue, which may impact stakeholder confidence and the company’s strategic positioning in the market.
More about M3
M3, Inc. is a company listed on the Tokyo Stock Exchange, operating in the healthcare and medical information services industry. The company focuses on providing medical-related services and products, leveraging technology to enhance healthcare solutions and information dissemination.
YTD Price Performance: 9.25%
Average Trading Volume: 100
Technical Sentiment Signal: Buy
Current Market Cap: $8.47B
See more data about 2413 stock on TipRanks’ Stock Analysis page.